Endocrinology, Vol 137, 4706-4712, Copyright © 1996 by Endocrine Society

ARTICLES

Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes

SR Tafuri
Department of Cell Biology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105, USA. Tafuris@aa.wl.com

Troglitazone is a member of the thiazolidinedione class of compounds, which act as insulin-sensitizing agents when administered to human patients and animal models displaying noninsulin-dependent diabetes mellitus. In Zucker rats, the antidiabetic activity is associated with increased glucose uptake in adipose tissue. To understand the direct effects troglitazone has on adipocyte metabolism, 3T3-L1 preadipocytes and adipocytes were treated with the compound. The addition of troglitazone enhanced the rate and percent differentiation of fibroblasts to adipocytes. Northern analysis indicated that during differentiation, expression of the adipocyte-specific transcription factor, CCAAT enhancer binding protein-alpha, increased more rapidly in troglitazone-treated cells, but did not change in fully differentiated adipocytes. To assess the metabolic consequences of troglitazone treatment, both basal and insulin-stimulated glucose uptake were monitored in treated cells. Troglitazone treatment increased basal glucose transport 1.5- to 2.0-fold, whereas insulin-stimulated uptake was unaffected. Enhanced basal transport was caused by an increased synthesis of both Glut1 glucose transporter messenger RNA and protein. These results suggest the possibility that in vivo, the troglitazone- dependent increase in glucose disposal may be attributable in part to modification in the expression of Glut1 in insulin-responsive tissues.

This article has been cited by other articles:

				F. Grun, H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D. M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates Mol. Endocrinol., September 1, 2006; 20(9): 2141 - 2155. [Abstract] [Full Text] [PDF]

				E. Burgermeister, A. Schnoebelen, A. Flament, J. Benz, M. Stihle, B. Gsell, A. Rufer, A. Ruf, B. Kuhn, H. P. Marki, et al. A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}) Recruits PPAR{gamma}-Coactivator-1{alpha}, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro Mol. Endocrinol., April 1, 2006; 20(4): 809 - 830. [Abstract] [Full Text] [PDF]

				J. Huang, S. H. Hsia, T. Imamura, I. Usui, and J. M. Olefsky Annexin II Is a Thiazolidinedione-Responsive Gene Involved in Insulin-Induced Glucose Transporter Isoform 4 Translocation in 3T3-L1 Adipocytes Endocrinology, April 1, 2004; 145(4): 1579 - 1586. [Abstract] [Full Text] [PDF]

				R. W. Valyasevi, D. A. Harteneck, C. M. Dutton, and R. S. Bahn Stimulation of Adipogenesis, Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}), and Thyrotropin Receptor by PPAR{gamma} Agonist in Human Orbital Preadipocyte Fibroblasts J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2352 - 2358. [Abstract] [Full Text] [PDF]

				M. L. Standaert, Y. Kanoh, M. P. Sajan, G. Bandyopadhyay, and R. V. Farese Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-{lambda}, and Glucose Transport in 3T3/L1 Adipocytes Endocrinology, May 1, 2002; 143(5): 1705 - 1716. [Abstract] [Full Text] [PDF]

				C. Nugent, J. B. Prins, J. P. Whitehead, D. Savage, J. M. Wentworth, V. K. Chatterjee, and S. O'Rahilly Potentiation of Glucose Uptake in 3T3-L1 Adipocytes by PPAR{gamma} Agonists Is Maintained in Cells Expressing a PPAR{gamma} Dominant-Negative Mutant: Evidence for Selectivity in the Downstream Responses to PPAR{gamma} Activation Mol. Endocrinol., October 1, 2001; 15(10): 1729 - 1738. [Abstract] [Full Text] [PDF]

				M. Shintani, H. Nishimura, S. Yonemitsu, Y. Ogawa, T. Hayashi, K. Hosoda, G. Inoue, and K. Nakao Troglitazone Not Only Increases GLUT4 but Also Induces Its Translocation in Rat Adipocytes Diabetes, October 1, 2001; 50(10): 2296 - 2300. [Abstract] [Full Text]

				F. Liu, J.-k. Kim, Y. Li, X.-q. Liu, J. Li, and X. Chen An Extract of Lagerstroemia speciosa L. Has Insulin-Like Glucose Uptake-Stimulatory and Adipocyte Differentiation-Inhibitory Activities in 3T3-L1 Cells J. Nutr., September 1, 2001; 131(9): 2242 - 2247. [Abstract] [Full Text] [PDF]

				H. S. Camp, A. Chaudhry, and T. Leff A Novel Potent Antagonist of Peroxisome Proliferator-Activated Receptor {{gamma}} Blocks Adipocyte Differentiation But Does Not Revert the Phenotype of Terminally Differentiated Adipocytes Endocrinology, July 1, 2001; 142(7): 3207 - 3213. [Abstract] [Full Text] [PDF]

				M. Iwata, T. Haruta, I. Usui, Y. Takata, A. Takano, T. Uno, J. Kawahara, E. Ueno, T. Sasaoka, O. Ishibashi, et al. Pioglitazone Ameliorates Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator-Activated Receptor-{gamma} Diabetes, May 1, 2001; 50(5): 1083 - 1092. [Abstract] [Full Text]

				S. Yonemitsu, H. Nishimura, M. Shintani, R. Inoue, Y. Yamamoto, H. Masuzaki, Y. Ogawa, K. Hosoda, G. Inoue, T. Hayashi, et al. Troglitazone Induces GLUT4 Translocation in L6 Myotubes Diabetes, May 1, 2001; 50(5): 1093 - 1101. [Abstract] [Full Text]

				Y. Kanoh, G. Bandyopadhyay, M. P. Sajan, M. L. Standaert, and R. V. Farese Rosiglitazone, Insulin Treatment, and Fasting Correct Defective Activation of Protein Kinase C-{{zeta}}/{{lambda}} by Insulin in Vastus Lateralis Muscles and Adipocytes of Diabetic Rats Endocrinology, April 1, 2001; 142(4): 1595 - 1605. [Abstract] [Full Text]

				I. Gabriely, R. Wozniak, M. Hawkins, and H. Shamoon Troglitazone Amplifies Counterregulatory Responses to Hypoglycemia in Nondiabetic Subjects J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 521 - 528. [Abstract] [Full Text]

				S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring Pathophysiology and Pharmacological Treatment of Insulin Resistance Endocr. Rev., December 1, 2000; 21(6): 585 - 618. [Abstract] [Full Text]

				R. Mukherjee, P. A. Hoener, L. Jow, J. Bilakovics, K. Klausing, D. E. Mais, A. Faulkner, G. E. Croston, and J. R. Paterniti Jr. A Selective Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}) Modulator Blocks Adipocyte Differentiation but Stimulates Glucose Uptake in 3T3-L1 Adipocytes Mol. Endocrinol., September 1, 2000; 14(9): 1425 - 1433. [Abstract] [Full Text]

				M.A. Breider, A.W. Gough, J.R. Haskins, G. Sobocinski, and F.A. De La Iglesia Troglitazone-Induced Heart and Adipose Tissue Cell Proliferation in Mice Toxicol Pathol, September 1, 1999; 27(5): 545 - 552. [Abstract] [PDF]

				D. N. Henry, J. V. Busik, F. C. Brosius III, and C. W. Heilig Glucose transporters control gene expression of aldose reductase, PKCalpha , and GLUT1 in mesangial cells in vitro Am J Physiol Renal Physiol, July 1, 1999; 277(1): F97 - F104. [Abstract] [Full Text] [PDF]

				S. Gasic, Y. Bodenburg, M. Nagamani, A. Green, and R. J. Urban Troglitazone Inhibits Progesterone Production in Porcine Granulosa Cells Endocrinology, December 1, 1998; 139(12): 4962 - 4966. [Abstract] [Full Text] [PDF]

				S. Ranganathan and P. A. Kern Thiazolidinediones Inhibit Lipoprotein Lipase Activity in Adipocytes J. Biol. Chem., October 2, 1998; 273(40): 26117 - 26122. [Abstract] [Full Text] [PDF]

				K. S. Park, T. P. Ciaraldi, K. Lindgren, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, S. R. Tufari, J. H. Veerkamp, A. Vidal-Puig, and R. R. Henry Troglitazone Effects on Gene Expression in Human Skeletal Muscle of Type II Diabetes Involve Up-Regulation of Peroxisome Proliferator-Activated Receptor-{gamma} J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2830 - 2835. [Abstract] [Full Text]

				K. S. Park, T. P. Ciaraldi, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, and R. R. Henry Troglitazone Regulation of Glucose Metabolism in Human Skeletal Muscle Cultures from Obese Type II Diabetic Subjects J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1636 - 1643. [Abstract] [Full Text]

				T.-Z. Su, M. Wang, D. L. Oxender, and A. R. Saltiel Troglitazone Increases System A Amino Acid Transport in 3T3-L1 Cells Endocrinology, March 1, 1998; 139(3): 832 - 837. [Abstract] [Full Text] [PDF]

				H. S. Camp and S. R. Tafuri Regulation of Peroxisome Proliferator-activated Receptor gamma Activity by Mitogen-activated Protein Kinase J. Biol. Chem., April 18, 1997; 272(16): 10811 - 10816. [Abstract] [Full Text] [PDF]

				Y. Kanoh, G. Bandyopadhyay, M. P. Sajan, M. L. Standaert, and R. V. Farese Thiazolidinedione Treatment Enhances Insulin Effects on Protein Kinase C-zeta /lambda Activation and Glucose Transport in Adipocytes of Nondiabetic and Goto-Kakizaki Type II Diabetic Rats J. Biol. Chem., May 26, 2000; 275(22): 16690 - 16696. [Abstract] [Full Text] [PDF]

				C. Nugent, J. B. Prins, J. P. Whitehead, J. M. Wentworth, V. K. K. Chatterjee, and S. O'Rahilly Arachidonic Acid Stimulates Glucose Uptake in 3T3-L1 Adipocytes by Increasing GLUT1 and GLUT4 Levels at the Plasma Membrane. EVIDENCE FOR INVOLVEMENT OF LIPOXYGENASE METABOLITES AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma J. Biol. Chem., March 16, 2001; 276(12): 9149 - 9157. [Abstract] [Full Text] [PDF]

				S. Schinner, C. Dellas, M. Schroder, C. A. Heinlein, C. Chang, J. Fischer, and W. Knepel Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor gamma through Inhibition of Pax6 Transcriptional Activity J. Biol. Chem., January 11, 2002; 277(3): 1941 - 1948. [Abstract] [Full Text] [PDF]